How healthy is the healthspan concept?

The paper examines the validity and utility of the healthspan concept within geroscience, questioning how claims of increased healthspan can be made in the absence of accepted or validated metrics. It highlights rapid growth in the term’s use despite definitional ambiguity and proposes that without standardized measures, assertions about interventions increasing healthspan are premature. The work underscores the importance of distinguishing healthspan from lifespan and the need for quantitative, comparable measures to assess interventions’ effects on health across the lifespan.

The author notes a dramatic increase in PubMed-indexed articles using “healthspan” since 2000, reflecting growing interest but also inconsistency in usage. Prior frameworks such as frailty indices and geropathology grading platforms are referenced as related but incomplete tools for capturing health across domains (Kane et al. 2017; Kim et al. 2017; Mitnitski et al. 2017; Snider et al. 2018). Recommendations for multi-domain, multi-age assessments (Richardson et al. 2016) are discussed, though the paper argues these do not resolve foundational measurement issues. Controversies in interpreting healthspan effects of interventions like rapamycin in mice and insulin/IGF-1 signaling mutants in C. elegans are cited as consequences of imprecise definitions (Johnson et al. 2013; Neff et al. 2013; Richardson 2013; Bansal et al. 2015; Ewald et al. 2018; Hahm et al. 2015). The societal and economic rationale for prioritizing healthy years of life is supported by prior analyses (Goldman et al. 2013; Sierra and Kohanski 2017).

This is a conceptual commentary rather than an empirical study. The paper critiques the commonly used definition of healthspan as the period of life spent in “good health,” noting problems of subjectivity, reversibility of health states, and ambiguity about which diseases or disabilities mark the end of healthspan. It proposes reframing health as a continuous, dynamic variable that generally declines with age and suggests the development of a comprehensive, standardized “healthspan index” encompassing multiple domains (physical, emotional, psychological, and functional). The author further proposes quantifying healthspan via the area under an individual’s longitudinal health curve (a composite health metric over time), enabling a single summary “healthspan metric” per individual and allowing statistically valid comparisons of interventions. A threshold-based definition could be applied if a discrete measure is needed, but the area-under-the-curve approach is emphasized as more informative.

• There are no accepted, validated metrics for measuring healthspan, despite frequent claims in the literature that interventions “increase” or “extend” healthspan.
• The use of “healthspan” has risen sharply: prior to 2000 only 14 PubMed-indexed papers referenced it in title/abstract; by mid-2018, more than 900 did, with 929 articles returned in a July 15, 2018 search.
• Health is not binary (good vs. bad); it is continuous and dynamic, making a simple time-based definition of healthspan problematic.
• Existing tools (e.g., frailty indices, geropathology platforms) capture aspects of aging but do not provide a comprehensive, validated healthspan metric across domains and time.
• Imprecise definitions likely fuel controversies around purported healthspan effects of interventions such as rapamycin in mice and genetic mutations in C. elegans.
• The paper proposes a framework for a quantitative healthspan metric based on a comprehensive index and the area under the health curve over time.
• Until standardized metrics exist, the term “healthspan” should be used only conceptually in scientific contexts, though it remains useful for public communication and advocacy.

By identifying the lack of standardized, validated measures, the paper explains why current claims of extended healthspan are not statistically defensible and may hinder scientific rigor. Treating health as a continuous, multidimensional construct directly addresses the problem of subjectivity and binary definitions. A proposed area-under-the-curve metric would allow rigorous comparisons of interventions and alignment of healthspan outcomes with lifespan effects. The author argues that, scientifically, restraint in using “healthspan” is warranted to avoid confusion, while publicly the concept remains valuable for communicating the goals of geroscience and garnering support due to its ethical and economic appeal.

The paper’s main contributions are: (1) clarifying conceptual and practical flaws in prevalent definitions and uses of healthspan; (2) advocating for development of a comprehensive, multidomain, longitudinal healthspan index; and (3) proposing an area-under-the-health-curve approach to yield a single quantitative healthspan metric for individuals. The author recommends refraining from making claims of increased healthspan in scientific literature until such metrics are established, while continuing to use the concept for broader outreach. Future research should prioritize defining, validating, and standardizing a healthspan assessment framework that enables statistically robust comparisons across interventions and species.

This is a perspective/commentary without empirical data collection or validation of the proposed metric. It does not specify concrete operational definitions, measurement instruments, weighting schemes, or statistical methods for constructing and validating a comprehensive healthspan index. The feasibility of capturing multidomain health longitudinally across species and settings remains untested within this work.